U.S. drugmaker J&J’s India sales dip 3 percent in 2017/18: filing


Johnson & Johnson’s sales in India dipped 3 percent in the year to March 2018, a regulatory filing showed on Thursday, as the U.S. drugmaker grappled with the country’s stringent medical device pricing policies.